Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Head and Neck Cancer

  Free Subscription

Articles published in Am J Surg

Retrieve available abstracts of 64 articles:
HTML format

Single Articles

    September 2021
  1. RAMONELL KM, Fazendin J
    The complex and heterogeneous entity of double adenomas in primary hyperparathyroidism.
    Am J Surg. 2021;222:481-482.

  2. GOODSELL KE, Ermer JP, Zaheer S, Kelz RR, et al
    Double adenoma as a cause of primary hyperparathyroidism: Asymmetric hyperplasia or a distinct pathologic entity?
    Am J Surg. 2021;222:483-489.
    PubMed     Abstract available

  3. LIMBERG J, Stefanova D, Thiesmeyer JW, Ullmann TM, et al
    Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.
    Am J Surg. 2021;222:562-569.
    PubMed     Abstract available

    August 2021
  4. BACK K, Lee J, Choe JH, Kim JH, et al
    Total thyroidectomy can be overtreatment in cN1a papillary thyroid carcinoma patients whose tumor is smaller than 1 cm.
    Am J Surg. 2021 Aug 12. pii: S0002-9610(21)00474.
    PubMed     Abstract available

  5. SINCLAIR CF, Tellez MJ, Pelaez-Cruz R, Diaz-Baamonde A, et al
    Continuous neuromonitoring during radiofrequency ablation of benign thyroid nodules provides objective evidence of laryngeal nerve safety.
    Am J Surg. 2021;222:354-360.
    PubMed     Abstract available

    July 2021
  6. MCDOW AD, Roman BR, Saucke MC, Jensen CB, et al
    Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
    Am J Surg. 2021;222:111-118.
    PubMed     Abstract available

  7. MUSAVI LS, Fadavi D, He W, Sacks JM, et al
    Impact of payer status and hospital volume on outcomes after head and neck oncologic reconstruction.
    Am J Surg. 2021;222:173-178.
    PubMed     Abstract available

    June 2021
  8. SCHWEITZER CL, Wiseman SM
    Adoption of intraoperative nerve monitoring for thyroidectomy: Supported by real-world NSQIP data.
    Am J Surg. 2021;221:1285-1290.

  9. WISEMAN SM, Saleh N, Tootooni A, Eshraghi P, et al
    Parathyroid identification during thyroid and parathyroid operations: A pilot study evaluating a novel low cost autofluorescence based device.
    Am J Surg. 2021;221:1150-1158.
    PubMed     Abstract available

    May 2021
  10. ESCE AR, Redemann JP, Sanchez AC, Olson GT, et al
    Predicting nodal metastases in papillary thyroid carcinoma using artificial intelligence.
    Am J Surg. 2021 May 13. pii: S0002-9610(21)00281.
    PubMed     Abstract available

  11. NYLEN C, Eriksson FB, Yang A, Aniss A, et al
    Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Am J Surg. 2021;221:886-892.
    PubMed     Abstract available

    April 2021
  12. WILSON M, Patel A, Goldner W, Baker J, et al
    Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Am J Surg. 2021;221:804-808.
    PubMed     Abstract available

    March 2021
  13. BORTZ MD, Khokar A, Winchester DJ, Moo-Young TA, et al
    Radioactive iodine-125 seed localization as an aid in reoperative neck surgery.
    Am J Surg. 2021;221:534-537.
    PubMed     Abstract available

  14. TAKEDA FR, Kodama Pertille Ramos MF, Pereira MA, Muniz RR, et al
    Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era.
    Am J Surg. 2021;221:631-636.
    PubMed     Abstract available

    February 2021
  15. SAHLI ZT, Canner JK, Zeiger MA, Mathur A, et al
    Association between age and disease specific mortality in medullary thyroid cancer.
    Am J Surg. 2021;221:478-484.
    PubMed     Abstract available

  16. WRENN SM, Wang TS, Toumi A, Kiernan CM, et al
    Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis.
    Am J Surg. 2021;221:448-454.
    PubMed     Abstract available

    January 2021
  17. ATAS H, Korukluoglu B, Ozdemir BA, Yaksi N, et al
    Diagnostic value of modified systemic inflammation score for prediction of malignancy in patients with indeterminate thyroid nodules.
    Am J Surg. 2021;221:117-121.
    PubMed     Abstract available

  18. SUTTON W, Canner JK, Rooper LM, Prescott JD, et al
    Is patient age associated with risk of malignancy in a >/=4 cm cytologically benign thyroid nodule?
    Am J Surg. 2021;221:111-116.
    PubMed     Abstract available

    November 2020
  19. WILSON M, Patel A, Goldner W, Baker J, et al
    Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Am J Surg. 2020;220:1169-1173.
    PubMed     Abstract available

    September 2020
  20. DREAM S, Wang TS
    The best localization is an experienced parathyroid surgeon.
    Am J Surg. 2020;220:532.

  21. SU A, Zhao W, Wu W, Wei T, et al
    The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.
    Am J Surg. 2020;220:634-641.
    PubMed     Abstract available

    August 2020
  22. SHENG L, Shi J, Han B, Lv B, et al
    Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma.
    Am J Surg. 2020;220:334-340.
    PubMed     Abstract available

    July 2020
  23. ZHENG R, Rios-Diaz AJ, Liem S, Devin CL, et al
    Is the placement of jejunostomy tubes in patients with esophageal cancer undergoing esophagectomy associated with increased inpatient healthcare utilization? An analysis of the National Readmissions Database.
    Am J Surg. 2020 Jul 25. pii: S0002-9610(20)30381.
    PubMed     Abstract available

  24. PLAT VD, Stam WT, Schoonmade LJ, Heineman DJ, et al
    Implementation of robot-assisted Ivor Lewis procedure: Robotic hand-sewn, linear or circular technique?
    Am J Surg. 2020;220:62-68.
    PubMed     Abstract available

    June 2020
  25. SYME N, Olson G, Spafford MF, Boyd N, et al
    Microvascular clamp technique as a reversible simulation of parathyroid gland excision.
    Am J Surg. 2020;219:943-946.
    PubMed     Abstract available

    May 2020
  26. SAKAI M, Sohda M, Saito H, Ubukata Y, et al
    Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer.
    Am J Surg. 2020 May 27. pii: S0002-9610(20)30296.
    PubMed     Abstract available

    March 2020
  27. KHOKAR A, Kuchta K, Abadin S, Moo-Young T, et al
    Discussion on: Increasing trend of bilateral neck exploration in primary hyperparathyroidism.
    Am J Surg. 2020;219:471.

    February 2020
  28. SCHIZAS D, Giannopoulos S, Vailas M, Mylonas KS, et al
    The impact of cirrhosis on esophageal cancer surgery: An up-to-date meta-analysis.
    Am J Surg. 2020 Feb 21. pii: S0002-9610(20)30114.
    PubMed     Abstract available

  29. SHIN CH, Roh JL, Song DE, Cho KJ, et al
    Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma.
    Am J Surg. 2020 Feb 16. pii: S0002-9610(20)30089.
    PubMed     Abstract available

    January 2020
  30. KIM Y, Roh JL, Song DE, Cho KJ, et al
    Risk factors for posttreatment recurrence in patients with intermediate-risk papillary thyroid carcinoma.
    Am J Surg. 2020 Jan 30. pii: S0002-9610(20)30062.
    PubMed     Abstract available

  31. SDRALIS E, Tzaferai A, Davakis S, Syllaios A, et al
    Reinforcement of intrathoracic oesophago-gastric anastomosis with fibrin sealant (Tisseel(R)) in oesophagectomy for cancer: A prospective comparative study.
    Am J Surg. 2020;219:123-128.
    PubMed     Abstract available

    December 2019
  32. SCHLOTTMANN F, Gaber C, Strassle PD, Charles AG, et al
    Health care disparities in colorectal and esophageal cancer.
    Am J Surg. 2019 Dec 23. pii: S0002-9610(19)31579.
    PubMed     Abstract available

    November 2019
  33. PURKAYASTHA J, Yadav J, Madhav S, Talukdar A, et al
    Letter to editor in response to article entitled "Feeding jejunostomy after esophagectomy cannot be routinely recommended. Analysis of nutritional benefits and catheter-related complications".
    Am J Surg. 2019;218:1030.

    August 2019
  34. HARBISON GJ, Vossler JD, Yim NH, Murayama KM, et al
    Outcomes of robotic versus non-robotic minimally-invasive esophagectomy for esophageal cancer: An American College of Surgeons NSQIP database analysis.
    Am J Surg. 2019 Aug 26. pii: S0002-9610(19)30353.
    PubMed     Abstract available

  35. VIKRAM S, Kumar P, Muhsin, Singh RB, et al
    Making a case for routine high resolution ultrasonography (HRUSG) of thyroid in Graves' disease.
    Am J Surg. 2019;218:442.

  36. MATTOO S, Agarwal A, Sabaretnam M, Chekavar A, et al
    Letter to the editor: "Coexistent thyroid nodules in patients with graves' disease: What is the frequency and the risk of malignancy?"
    Am J Surg. 2019;218:443.

  37. JEREMIASEN M, Walther B, Djerf P, Stael von Holstein C, et al
    Thoracoabdominal gastrectomy and distal 2/3 esophageal resection with wide lymph node dissection for type II and III adenocarcinoma at the gastro-esophageal junction.
    Am J Surg. 2019;218:329-334.
    PubMed     Abstract available

  38. AZAB B, Macedo FI, Cass SH, Ripat C, et al
    A large national comparative study of clinicopathological features and long-term survivals between esophageal gastrointestinal stromal tumor and leiomyosarcoma.
    Am J Surg. 2019;218:323-328.
    PubMed     Abstract available

    July 2019
  39. HIRATA A, Hayano K, Ohira G, Imanishi S, et al
    Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy.
    Am J Surg. 2019 Jul 29. pii: S0002-9610(19)30265.
    PubMed     Abstract available

  40. MATTOO S, Chekavar A
    Letter to the editor in response to the article "The presence of papillary features in thyroid nodules diagnosed as atypia of undetermined significance or follicular lesion of undetermined significance increases cancer risk and should influence treatm
    Am J Surg. 2019;218:234.

  41. WIRSCHING A, Boshier PR, Krishnamoorthi R, Larsen MC, et al
    Endoscopic therapy and surveillance versus esophagectomy for early esophageal adenocarcinoma: A review of early outcomes and cost analysis.
    Am J Surg. 2019;218:164-169.
    PubMed     Abstract available

    March 2019
  42. HAWASLI A, Camero L, Williams T, Ambrosi G, et al
    The original Ivor Lewis two stage esophagectomy revisited in the era of minimally invasive surgery.
    Am J Surg. 2019;217:454-457.
    PubMed     Abstract available

    January 2019
  43. ALVAREZ-SARRADO E, Mingol Navarro F, J Rosellon R, Ballester Pla N, et al
    Feeding Jejunostomy after esophagectomy cannot be routinely recommended. Analysis of nutritional benefits and catheter-related complications.
    Am J Surg. 2019;217:114-120.
    PubMed     Abstract available

    March 2018

  44. Discussion of: Can parathyroid hyperplasia be predicted preoperatively?
    Am J Surg. 2018;215:393-394.

  45. MCHENRY CR, Shi HH
    Can parathyroid hyperplasia be predicted preoperatively?
    Am J Surg. 2018;215:389-392.
    PubMed     Abstract available

    January 2018
  46. SATO Y, Motoyama S, Wakita A, Kawakita Y, et al
    TLR3 expression status predicts prognosis in patients with advanced thoracic esophageal squamous cell carcinoma after esophagectomy.
    Am J Surg. 2018 Jan 29. pii: S0002-9610(17)30940.
    PubMed     Abstract available

    December 2017
  47. CHO E, Kim EK, Moon HJ, Yoon JH, et al
    High suspicion US pattern on the ATA guidelines, not cytologic diagnosis, may be a predicting marker of lymph node metastasis in patients with classical papillary thyroid carcinoma.
    Am J Surg. 2017 Dec 14. pii: S0002-9610(17)31367.
    PubMed     Abstract available

    October 2017
  48. SAEKI H, Nakashima Y, Hirose K, Sasaki S, et al
    "Energy-less technique" with mini-clips for recurrent laryngeal nerve lymph node dissection in prone thoracoscopic esophagectomy for esophageal cancer.
    Am J Surg. 2017 Oct 23. pii: S0002-9610(17)31290.
    PubMed     Abstract available

    September 2017
  49. VASILEIADIS I, Boutzios G, Karalaki M, Misiakos E, et al
    Papillary thyroid carcinoma of the isthmus: Total thyroidectomy or isthmusectomy?
    Am J Surg. 2017 Sep 19. pii: S0002-9610(17)30657.
    PubMed     Abstract available

    August 2017
  50. TERP FJEDERHOLT K, Svendsen LB, Mortensen FV
    Perioperative blood transfusions increases the risk of anastomotic leakage after surgery for GEJ-cancer.
    Am J Surg. 2017;214:293-298.
    PubMed     Abstract available

    July 2017
  51. JHA CK, Yadav SK, Bichoo RA
    Comment on article entitled "Is intraoperative parathyroid hormone monitoring necessary for primary hyperparathyroidism with concordant preoperative imaging?"
    Am J Surg. 2017;214:161-162.

    June 2017
  52. JHA CK, Bichoo RA, Yadav SK, Sonthineni C, et al
    Ambulatory bilateral neck exploration for primary hyperparathyroidism: Is it safe?
    Am J Surg. 2017;213:1191-1192.

    May 2017
  53. WONG J, Liu K, Siu C, Jones S, et al
    Management of PET diagnosed thyroid incidentalomas in British Columbia Canada: Critical importance of the PET report.
    Am J Surg. 2017;213:950-957.
    PubMed     Abstract available

  54. INMAN A, Liu K, Ong K, Tiwari P, et al
    Completeness of ultrasound reporting impacts time to biopsy for benign and malignant thyroid nodules.
    Am J Surg. 2017;213:931-935.
    PubMed     Abstract available

  55. MCLAREN PJ, Barnes AP, Terrell WZ, Vaccaro GM, et al
    Specific gene expression profiles are associated with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinoma.
    Am J Surg. 2017;213:915-920.
    PubMed     Abstract available

    April 2017
  56. OKI S, Toiyama Y, Okugawa Y, Shimura T, et al
    Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients.
    Am J Surg. 2017 Apr 25. pii: S0002-9610(16)30728.
    PubMed     Abstract available

    March 2017
  57. SHI H, Bobanga I, McHenry CR
    Are large thyroid nodules classified as benign on fine needle aspiration more likely to harbor cancer?
    Am J Surg. 2017;213:464-466.
    PubMed     Abstract available

  58. BOBANGA ID, McHenry CR
    Is intraoperative parathyroid hormone monitoring necessary for primary hyperparathyroidism with concordant preoperative imaging?
    Am J Surg. 2017;213:484-488.
    PubMed     Abstract available

  59. BRADLEY SJ, Knodle KF
    Ultrasound based focused neck exploration for primary hyperparathyroidism.
    Am J Surg. 2017;213:452-455.
    PubMed     Abstract available

    February 2017
  60. DENIWAR A, Hammad AY, Ali DB, Alsaleh N, et al
    Optimal timing for a repeat fine-needle aspiration biopsy of thyroid nodule following an initial nondiagnostic fine-needle aspiration.
    Am J Surg. 2017;213:433-437.
    PubMed     Abstract available

    December 2016
  61. AL-HILLI Z, Strajina V, McKenzie TJ, Thompson GB, et al
    The role of lateral neck ultrasound in detecting single or multiple lymph nodes in papillary thyroid cancer.
    Am J Surg. 2016;212:1147-1153.
    PubMed     Abstract available

    From the laboratory bench to the operating room: the role of the surgeon in cancer prevention.
    Am J Surg. 2016;212:1035-1038.
    PubMed     Abstract available

    October 2016
  63. JHA CK, Yadav SK, Bichoo RA
    Letter to editor in response to article entitled "Recurrence in patients with clinically early-stage papillary thyroid carcinoma according to tumor size surgical extent" by Kim JW et al published in Am J Surg. 2016 Sep;212(3):419-425.e1. doi: 10.1016/
    Am J Surg. 2016 Oct 11. pii: S0002-9610(16)30612.

  64. GROSHEVA M, Horstmann L, Volk GF, Holler C, et al
    Frey's syndrome after superficial parotidectomy: role of the sternocleidomastoid muscle flap: a prospective nonrandomized controlled trial.
    Am J Surg. 2016;212:740-747.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.